Journals / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 1

An evaluation of risk factors affecting amputation in patients with diabetic foot Infection

Pages
49–54
Publication Date
2021-01-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PAD, osteomyelitis, and history of repeated hospitalizations are separate risk factors for amputation in patients with diabetic foot ulcers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Diabetic foot infections are one of the most common complications of diabetes and generally result in lower extremity amputations.
📊
Key Findings & Data:Materials and Methods: This prospective cohort study involved 137 patients diagnosed with diabetic foot infection in a university hospital diabetic foot clinic.
💡
Conclusion & Impact:Conclusion: PAD, osteomyelitis, and history of repeated hospitalizations are separate risk factors for amputation in patients with diabetic foot ulcers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetic foot · amputation · risk factors

Abstract

Introduction: Diabetic foot infections are one of the most common complications of diabetes and generally result in lower extremity amputations. Aim: The purpose of this study is to investigate risk factors affecting amputation in patients diagnosed with diabetic foot ulcer. Materials and Methods: This prospective cohort study involved 137 patients diagnosed with diabetic foot infection in a university hospital diabetic foot clinic. Results: The mean age of the participants was 60.5±10.1 years, and 70.8% (n=97) were men. The majority of patients (62.0%) were educated to elementary or middle school level, while 26.3% were illiterate. Mean duration of diabetes was 13.3±6.2 years. Hypertension was present in 48.2% of patients, hypercholesterolemia in 31.4%, cardiovascular disease (CVD) in 38%, peripheral artery disease (PAD) in 21.2%, peripheral venous insufficiency in 10.2%, and polyneuropathy in 70.1%, and 9.5% were receiving hemodialysis. According to the Infectious Diseases Society of America classification, moderate foot ulcers were present in 60.6% of patients, mild ulcers in 34.3%, and severe ulcers in 5.1%. Forty-six percent of patients were diagnosed with osteomyelitis during follow-up. Amputation was present in 28.5% (n=39) of the patients followed-up due to foot ulcers. PAD increased the risk of amputation 2.7-fold (95% CI: 1.02-7.14), osteomyelitis 2.6-fold (95% CI: 1.10-6.16), and repeated hospitalizations 5.9-fold (95% CI: 2.25-15.33). Growth was observed in 72.6% of patients without amputation, 76.5% were polymicrobial, and 65.9% of antibiogram results were multidrug resistant. No significant difference was observed among the patients in terms of multidrug resistance (p=0.468). Conclusion: PAD, osteomyelitis, and history of repeated hospitalizations are separate risk factors for amputation in patients with diabetic foot ulcers.

🔖

Cite This Article

ALAY, H., YILMAZ, S., CAN, F. K., PARLAK, M. (2021). An evaluation of risk factors affecting amputation in patients with diabetic foot Infection. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 1, 49–54. https://ajindex.com/articles/777008

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 8th edition, 2017.
  2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med 2017; 49: 106-16.
  3. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16: S75-83. Chronic Complications of Diabetes, Diabetes and Foot. National Diabetes Consensus Group. TURKDIAB Diabetes Diagnosis and Treatment Guideline 2019; 121-30.
  4. Brownrigg JRW, Griffin M, Hughes CO, et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J Vasc Surg 2014; 60: 982–6.
  5. Turhan V, Mutluoglu M, Acar A, et al. Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers. J Infect Dev Ctries 2013; 7: 707-12.
  6. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376: 2367. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: 132-73.
  7. Neves J, Matias R, Formiga A, et al. O pé diabético com infecção aguda: tratamento no Serviço de Urgência em Portugal. Rev Port Cir 2013; 27: 19-36. Sánchez-Sánchez M, Cruz-Pulido WL, Bladinieres-Cámara E, AlcaláDurán R, Rivera-Sánchez G, Bocanegra-García V. bacterial prevalence and antibiotic resistance in clinical isolates of diabetic foot ulcers in the Northeast of Tamaulipas, Mexico. Int J Low Extrem Wounds 2017; 16: 129-34.
  8. Spicler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Luis Pasteur to ‘crime scene investigation’. BMC Med 2015; 13: 1-13.
  9. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drugresistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–81.
  10. Barwell ND, Devers MC, Kennon B, et al. Scottish diabetes foot action group. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract 2017; 71: 10.1111/ijcp.13006. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16: 75-83.
  11. Baba M, Davis WA, Norman PE, D